İrkeç, C. And Altan, N. 2017. Serum fractalkine levels in patients with vascular dementia,Alzheimer's disease and mild cognitive impairment. Journal Of The Neurological Sciences , vol.381 , 663.

İrkeç, C., & Altan, N., (2017). Serum fractalkine levels in patients with vascular dementia,Alzheimer's disease and mild cognitive impairment. Journal Of The Neurological Sciences , vol.381, 663.

İrkeç, CEYLA, And Nilgün Altan. "Serum fractalkine levels in patients with vascular dementia,Alzheimer's disease and mild cognitive impairment," Journal Of The Neurological Sciences , vol.381, 663, 2017

İrkeç, CEYLA And Altan, Nilgün. "Serum fractalkine levels in patients with vascular dementia,Alzheimer's disease and mild cognitive impairment." Journal Of The Neurological Sciences , vol.381, pp.663, 2017

İrkeç, C. And Altan, N. (2017) . "Serum fractalkine levels in patients with vascular dementia,Alzheimer's disease and mild cognitive impairment." Journal Of The Neurological Sciences , vol.381, p.663.

@article{article, author={CEYLA İRKEÇ And author={Nilgün Altan}, title={Serum fractalkine levels in patients with vascular dementia,Alzheimer's disease and mild cognitive impairment}, journal={Journal Of The Neurological Sciences}, year=2017, pages={663} }